Table 2

Distribution of RAD51 genotype and allele among cancer patients and controls
First author Year Case GC CC Control GC CC Case C Control C HWE
GG GG G G
1. Lu JC 2006 624 91 1 622 96 1 1339 93 1340 98 0.17
2. Gil J 2011 100 29 4 73 27 0 229 37 173 27 0.19
3. Webb PM 2005 457 85 4 971 145 10 999 93 2087 165 0.08
4. Gresner P 2012 67 13 1 71 14 2 147 15 156 18 0.22
5. Seedhouse C 2004 210 44 3 166 18 2 464 50 350 22 0.08
6. Jawad M 2006 210 44 3 166 18 2 464 50 350 22 0.08
7. Krupa R 2011 61 36 3 36 35 29 158 42 107 93 0.003
8. Sliwinski T 2010 138 145 5 258 64 32 421 155 580 128 0.28
9. Hamdy MS 2011 39 9 2 26 3 1 87 13 55 5 0.06
10. Liu L 2011 72 25 8 511 175 18 169 25 1197 211 0.52
11. Romanowicz- MakowskaH 2012 51 56 213 91 164 65 158 482 346 294 0.57
12. Werbouck J 2008 136 15 1 134 23 0 287 17 291 23 0.32
13. Romanowicz-MakowskaH 2011 13 15 92 33 69 18 41 199 135 105 0.07
14. Bhatla D 2008 374 73 5 555 85 6 821 83 1195 97 0.18
15. Voso MT 2007 125 33 2 142 18 1 283 37 302 20 0.61
16. Mucha B 2012 161 34 5 157 37 6 356 44 351 49 0.05
17. Zhang ZQ 2009 117 47 2 315 123 20 281 51 753 163 0.08
18. Auranen A (Danish) 2005 241 36 1 616 78 5 518 38 1310 88 0.15
18. Auranen A (UK) 2005 642 84 3 745 100 2 1368 90 1590 104 0.48
18. Auranen A (USA) 2005 270 52 4 357 61 1 592 60 775 63 0.34
21. Yang L 2011 268 101 10 511 175 18 637 121 1197 211 0.52
22. Rollinson S 2006 431 34 1 817 115 4 896 36 1749 123 0.98

HWE: P value for Hardy-Weinberg equilibrium for RAD51 135G/C polymorphism among controls.

Cheng et al.

Cheng et al. Diagnostic Pathology 2014 9:18   doi:10.1186/1746-1596-9-18

Open Data